BREAKING
Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 14 hours ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 15 hours ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 16 hours ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 4 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 14 hours ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 15 hours ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 16 hours ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 4 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago
ADVERTISEMENT
Market News

Boston Scientific Corporation (BSX): Q4 2019 Earnings Snapshot

—  Boston Scientific (NYSE: BSX) reported earnings of $0.46 per share in the fourth quarter of 2019, vs. $0.44 per share expected. — Total revenue grew 13.4% to $2.91 billion, vs. $2.92 billion expected. The revenue growth was spread across all segments and all geographic regions in Q4.   — Expects 10-12% growth in revenues for the fiscal […]

$BSX February 5, 2020 1 min read
NYSE
$BSX · Earnings

—  Boston Scientific (NYSE: BSX) reported earnings of $0.46 per share in the fourth quarter of 2019, vs. $0.44 per share expected. — Total revenue grew 13.4% to $2.91 billion, vs. $2.92 billion expected. The revenue growth was spread across all segments and all geographic regions in Q4.   — Expects 10-12% growth in revenues for the fiscal […]

· February 5, 2020

—  Boston Scientific (NYSE: BSX) reported earnings of $0.46 per share in the fourth quarter of 2019, vs. $0.44 per share expected.

— Total revenue grew 13.4% to $2.91 billion, vs. $2.92 billion expected. The revenue growth was spread across all segments and all geographic regions in Q4.  

Boston Scientific Q4 2019 earnings infographic

— Expects 10-12% growth in revenues for the fiscal year 2020 on a reported basis. Adjusted EPS for this period is projected in the range of $1.74 to $1.79 per share.

— BSX shares were up 0.75% immediately following the announcement. 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT
ADVERTISEMENT